vs
NexPoint Residential Trust, Inc.（NXRT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
NexPoint Residential Trust, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍（$62.1M vs $35.5M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -2.7%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -4.1%）
NexPoint Residential Trust是一家公开上市的房地产投资信托，主要收购、翻新并运营美国阳光地带高增长市场的多户住宅物业，旗下资产以经济型和中端公寓社区为主，旨在通过稳定的租金收入增长和长期资产增值为投资者创造回报。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NXRT vs RXRX — 直观对比
营收规模更大
NXRT
是对方的1.7倍
$35.5M
营收增速更快
RXRX
高出684.4%
-2.7%
两年增速更快
RXRX
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 8.4% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | -2.7% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NXRTRXRX
| Q4 25 | $62.1M | $35.5M | ||
| Q3 25 | $62.8M | $5.2M | ||
| Q2 25 | $63.1M | $19.2M | ||
| Q1 25 | $63.2M | $14.7M | ||
| Q4 24 | $63.8M | $4.5M | ||
| Q3 24 | $64.1M | $26.1M | ||
| Q2 24 | $64.2M | $14.4M | ||
| Q1 24 | $67.6M | $13.8M |
净利润NXRTRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-7.8M | $-162.3M | ||
| Q2 25 | $-7.0M | $-171.9M | ||
| Q1 25 | $-6.9M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $-8.9M | $-95.8M | ||
| Q2 24 | $10.6M | $-97.5M | ||
| Q1 24 | $26.3M | $-91.4M |
毛利率NXRTRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率NXRTRXRX
| Q4 25 | 8.4% | -304.8% | ||
| Q3 25 | 11.8% | -3327.6% | ||
| Q2 25 | 12.5% | -916.8% | ||
| Q1 25 | 11.7% | -1297.9% | ||
| Q4 24 | 18.0% | -4042.4% | ||
| Q3 24 | 8.7% | -377.1% | ||
| Q2 24 | 39.7% | -697.4% | ||
| Q1 24 | 60.7% | -698.4% |
净利率NXRTRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -12.4% | -3135.3% | ||
| Q2 25 | -11.1% | -894.2% | ||
| Q1 25 | -10.9% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | -13.8% | -367.5% | ||
| Q2 24 | 16.5% | -676.6% | ||
| Q1 24 | 38.9% | -662.4% |
每股收益（稀释后）NXRTRXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.31 | $-0.36 | ||
| Q2 25 | $-0.28 | $-0.41 | ||
| Q1 25 | $-0.27 | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | $-0.35 | $-0.34 | ||
| Q2 24 | $0.40 | $-0.40 | ||
| Q1 24 | $1.00 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $13.7M | $743.3M |
| 总债务越低越好 | $1.6B | $9.6M |
| 股东权益账面价值 | $295.5M | $1.1B |
| 总资产 | $1.9B | $1.5B |
| 负债/权益比越低杠杆越低 | 5.39× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资NXRTRXRX
| Q4 25 | $13.7M | $743.3M | ||
| Q3 25 | $10.8M | $659.8M | ||
| Q2 25 | $13.6M | $525.1M | ||
| Q1 25 | $23.7M | $500.5M | ||
| Q4 24 | $23.1M | $594.4M | ||
| Q3 24 | $17.4M | $427.6M | ||
| Q2 24 | $21.3M | $474.3M | ||
| Q1 24 | $37.2M | $296.3M |
总债务NXRTRXRX
| Q4 25 | $1.6B | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | $1.5B | — |
股东权益NXRTRXRX
| Q4 25 | $295.5M | $1.1B | ||
| Q3 25 | $322.9M | $1.0B | ||
| Q2 25 | $347.9M | $919.1M | ||
| Q1 25 | $379.9M | $933.9M | ||
| Q4 24 | $410.4M | $1.0B | ||
| Q3 24 | $447.1M | $524.6M | ||
| Q2 24 | $491.1M | $584.4M | ||
| Q1 24 | $512.8M | $401.2M |
总资产NXRTRXRX
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $1.8B | $1.4B | ||
| Q2 25 | $1.9B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.9B | $1.4B | ||
| Q3 24 | $2.0B | $726.5M | ||
| Q2 24 | $2.0B | $775.9M | ||
| Q1 24 | $2.0B | $557.8M |
负债/权益比NXRTRXRX
| Q4 25 | 5.39× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | 2.92× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $83.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流NXRTRXRX
| Q4 25 | $83.6M | $-46.1M | ||
| Q3 25 | $29.3M | $-117.4M | ||
| Q2 25 | $19.9M | $-76.4M | ||
| Q1 25 | $28.3M | $-132.0M | ||
| Q4 24 | $73.6M | $-115.4M | ||
| Q3 24 | $27.8M | $-59.2M | ||
| Q2 24 | $19.7M | $-82.2M | ||
| Q1 24 | $19.7M | $-102.3M |
自由现金流NXRTRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率NXRTRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度NXRTRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率NXRTRXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 0.75× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
